TREA

79345867 - RECOMBUMIN

Follow

Information

  • Trademark
  • 79345867
  • Serial Number
    79345867
  • Registration Number
    7362015
  • Filing Date
    May 26, 2022
    2 years ago
  • Registration Date
    April 23, 2024
    8 months ago
  • Transaction Date
    November 09, 2024
    a month ago
  • Status Date
    April 23, 2024
    8 months ago
  • Published for Opposition Date
    February 06, 2024
    11 months ago
  • Location Date
    April 23, 2024
    8 months ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    PERKINS, ELLEN
  • Attorney Docket Number
    ALBU 2308202
    Attorney Name
    Karen Lim
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
RECOMBUMIN
Case File Statements
  • GS0051: Pharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; albumin, chemical preparations, synthetic peptides, protein supplements, monoclonal, polyclonal, immunological, native and recombinant antibodies for medical and veterinary use, cells for medical and veterinary use, viruses, live viruses, live- attenuated viruses, attenuated viruses, and virus-like particles and viral vectors for medical and veterinary use, vaccines, growth factors for medical and veterinary use, immune modulators for medical and veterinary use, monoclonal antibodies, biological tissue and tissue cultures, recombinant proteins for medical and veterinary use, nucleic acid sequences, blood plasma, blood components for medical and veterinary use, all being for pharmaceutical use for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical purposes; albuminous preparations for medical or veterinary purposes; recombinant albumin for biological therapeutic purposes
  • GS0011: Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research
Case File Event Statements
  • 7/21/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 7/27/2022 - 2 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 7/29/2022 - 2 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/2/2022 - 2 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/29/2023 - a year ago
    5 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/7/2023 - a year ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/15/2023 - a year ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/16/2023 - a year ago
    8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/2/2023 - a year ago
    9 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/3/2023 - a year ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/3/2023 - a year ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/23/2023 - a year ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/3/2023 - a year ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/3/2023 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/3/2023 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/27/2023 - a year ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/27/2023 - a year ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 12/31/2023 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/13/2024 - 11 months ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 1/17/2024 - 11 months ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/17/2024 - 11 months ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/17/2024 - 11 months ago
    21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/5/2024 - 11 months ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/6/2024 - 11 months ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/6/2024 - 11 months ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/23/2024 - 8 months ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/23/2024 - 8 months ago
    27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/24/2024 - 5 months ago
    28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/23/2024 - 2 months ago
    29 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 10/23/2024 - 2 months ago
    30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/9/2024 - a month ago
    31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO